Factor XIII Val34Leu variant protects against coronary artery diseas. A meta-analysis

Thrombosis and Haemostasis

Volumn 97, Issue 3, 2007, Pages 458-463

  Vokó, Zoltán ^a,b   Bereczky, Zsuzsanna ^b   Katona, Éva ^b   Ádány, Róza ^a,b   Muszbek, László ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Coronary disease; Factor XIII; Meta analysis; Polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 13;

ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; BAYES THEOREM; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DATA BASE; EVIDENCE BASED MEDICINE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HEART PROTECTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; QUANTITATIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

AMINO ACID SUBSTITUTION; BAYES THEOREM; CORONARY ARTERIOSCLEROSIS; FACTOR VIII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LEUCINE; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; VALINE;

EID: 33947330306     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-11-0676     Document Type: Article

References (42)

1. Muszbek L, Adany R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 1996; 33: 357-421.
2. Mikkola H, Syrjala M, Rasi V, et al. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-525.
3. Balogh I, Szoke G, Karpati L, et al. Va134Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000; 96: 2479-2486.
4. Wartiovaara U, Mikkola H, Szoke G, et al. Effect of Va134Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 2000; 84: 595-600.
5. Ariens RA, Philippou H, Nagaswami C, et al. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000; 96: 988-995.
6. Lim BC, Ariens RA, Carter AM, et al. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 2003; 361: 1424-1431.
7. Wells PS, Anderson JL, Scarvelis DK, et al. Factor XIII Va134Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol 2006; 164: 101-109.
8. Kohler HP, Stickland MH, Ossei-Gerning N, et al. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
9. Wartiovaara U, Perola M, Mikkola H, et al. Association of FXIII Va134Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 1999; 142: 295-300.
10. Canavy I, Henry M, Morange PE, et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 2000; 83: 212-216.
11. Corral J, Gonzalez-Conejero R, Iniesta JA, et al. The FXIII Va134Leu polymorphism in venous and arterial thromboembolism. Haematologica 2000; 85: 293-297.
12. Franco RF, Pazin-Filho A, Tavella MH, et al. Factor XIII va134leu and the risk of myocardial infarction. Haematologica 2000; 85: 67-71.
13. Gemmati D, Serino ML, Ongaro A, et al. A common mutation in the gene for coagulation factor XIII-A (Va134Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 2001; 67: 183-188.
14. Warner D, Mansfield MW, Grant PJ. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost 2001; 85: 408-411.
15. Aleksic N, Ahn C, Wang YW, et al. Factor XIIIA Va134Leu polymorphism does not predict risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb Vasc Biol 2002; 22: 348-352.
16. Kakko S, Elo T, Tapanainen JM, et al. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 2002; 32: 643-648.
17. Reiner AP, Frank MB, Schwartz SM, et al. Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol 2002; 116: 376-382.
18. Doggen CJ, Reiner AP, Vos HL et al. Two factor XIII gene polymorphisms associated with a structural and functional defect and the risk of myocardial infarction in men. J Thromb Haemost 2003; 1: 2056-2058.
19. Reiner AP, Heckbert SR, Vos HL, et al. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood 2003; 102: 25-30.
20. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 2003; 107: 1117-1122.
21. Butt C, Zheng H, Randell E, et al. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction. Blood 2003; 101: 3037-3041.
22. Roldan V, Corral J, Marin F, et al. Role of factor XIII Va134Leu polymorphism in patients <45 years of age with acute myocardial infarction. Am J Cardiol 2003; 91: 1242-1245.
23. Hancer VS, Diz-Kucukkaya R, Bilge AK et al. The association between factor XIII Va134Leu polymorphism and early myocardial infarction. Circ J 2006; 70: 239-242.
24. Marin F, Roldan V Sogor F. Factor XIII Va134Leu polymorphism and premature myocardial infarction. (Spanish) Rev Esp Cardiol 2002; 55: 1106-1107.
25. Boekholdt SM, Sandhu MS, Wareham NJ, et al. Fibrinogen plasma levels modify the association between the factor XIII Va134Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study. J Thromb Haemost 2006; 4: 2204-2209.
26. Odeberg J, Freitag M, Odeberg H, et al. Severity of acute coronary syndrome is predicted by interactions between fibrinogen concentrations and polymorphisms in the GPIIIa and FXIII genes. J Thromb Haemost 2006; 4: 909-912.
27. Bereczky Zs, Balogh E, Katona É, et al. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Va134Leu polymorphism and fibrinogen concentration in the high risk Hungarian population. Thromb Res 2007; doi:10.1016/ j.thromres.2006.12.013.
28. World Health Organization. Manual of the International Classification of Disease, Injuries and Causes of Death, Volume 1, 9th revision. Geneva: WHO, 1977.
29. Rothman KJ. Modern epidemiology. 1st ed. Boston: Little, Brown and Company, 1986; 145-146.
30. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-129.
31. Sutton AJ, Abrams KR, Jones DR, et al. Methods for meta-analysis in medical research. Chicester: John Wiley & Sons Ltd., 2006.
32. Stata Statistical Software: Release 9. College Station, Texas: StataCorp LP, 2005.
33. Stara Technical Bulletin Reprints: Volume 7. College Station, Texas: StataCorp LP, 1998; 100-108.
34. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-634.
35. Stata Technical Bulletin Reprints: Volume 7. College Station, Texas: StataCorp LP, 1998: 125-133.
36. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lipincott-Raven Publishers, 1998; 9-11.
37. McKee M, Zatonski W. How the cardiovascular burden of illness is changing in eastern Europe. Evid Based Cardiovasc Med 1998; 2: 39-41.
38. Kobbervig C, Williams E. FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophys Chem 2004; 112: 223-228.
39. Kohler HP, Mansfield MW, Clark PS, et al. Interaction between insulin resistance and factor XIII Va134Leu in patients with coronary artery disease. Thromb Haemost 1999; 82: 1202-1203.
40. Rubens FD, Perry DW, Hatton MW, et al. Platelet accumulation on fibrin-coated polyethylene: role of platelet activation and factor XIII. Thromb Haemost 1995; 73: 850-856.
41. Harsfalvi J, Legrand C, Muszbek L. Platelet adhesion to FXIII-cross-linked fibrin at static and dynamic conditions. Thromb Haemost 1997; Suppl: S124 (abstract).
42. Rothman K, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1998: 286-287.